Sonic Healthcare USA has launched a multiplex RT-PCR assay that combines testing for SARS-CoV-2 (COVID-19) and Influenza A/B with a single specimen collection.

Today, Sonic Healthcare USA (Sonic) was awarded a contract from the National Institutes of Health (NIH) Rapid Acceleration of Diagnostics Advanced Technology Platforms (RADx-ATP) initiative.

A new validation study published today, “Thyroid Cytology Smear Slides: An Untapped Resource for ThyroSeq Testing."

Over the last few weeks, our network of clinical laboratories throughout the United States has seen a significant increase in demand for COVID-19 molecular testing.

WASHINGTON, D.C – Following a surge of new COVID-19 cases in the United States, ACLA President Julie Khani issued the following statement:

Sonic Healthcare USA's Bernhardt Laboratories, located in Jacksonville, Florida, hosted U.S. Health and Human Services Secretary Alex Azar at their facility last week.  Bernhardt Laboratories is an...

Sonic Healthcare USA's COVID-19 Taskforce Medical and Scientific Advisors have developed a novel Return-to-Work protocol consisting of laboratory testing algorithms intended to help guide employers...

Sonic Healthcare USA's network of clinical laboratories has begun performing antibody testing for SARS-CoV-2 (COVID-19) to complement our existing molecular PCR testing. Sonic Healthcare USA labora...

Sonic Healthcare USA’s dedicated scientific, medical and operational experts have established SARS-CoV-2/COVID-19 testing in six of our laboratories across the country since March 10, 2020. Our res...

This week, Sonic Healthcare USA's network of clinical laboratories began testing for SARS-CoV-2 (COVID-19). Sonic Healthcare USA has worked closely with its scientific partners and medical and oper...